CONSTELLATION PHARMACEUTICALS, INC.
215 First Street, Suite 200
Cambridge, MA 02142
August 14, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Constellation Pharmaceuticals, Inc. |
Registration Statement on FormS-3
FileNo. 333-232992
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Constellation Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on FormS-3 (FileNo. 333-232992), so that it may become effective at 4:30 p.m. Eastern time on August 16, 2019, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
CONSTELLATION PHARMACEUTICALS, INC. | ||
By: | /s/ Karen Valentine | |
Name: Title: | Karen Valentine Chief Legal Officer and General Counsel |
cc: | Lia Der Marderosian |
Wilmer Cutler Pickering Hale and Dorr LLP